22 completed. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Completed 22 |
Follow Burns: new trials by email Literature Review of Burns trials Research Report on Burns
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oliceridine in Patients With Acute Burn Injuries Oliceridine, Historical opioid use - Acute Pain, Burns | Phase 4 | Completed | University of Tennessee | 31 | 2023-04-01 | 2023-10-26 |
| Vitamin D Deficiency in Adults Following a Major Burn Injury Ergocalciferol Capsules - Vitamin D Deficiency, Burns | Phase 4 | Completed | University of Texas Southwestern Medical Center | 48 | 2022-09-29 | 2025-12-15 |
| Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale Platelet Rich Plasma plus fat grafting - Burn | Phase 4 | Completed | Dow University of Health Sciences | 64 | 2021-03-01 | 2023-02-21 |
| The Use of a Platform Wound Device for Reducing Infection Gentamycin with Platform Wound Device - Wounds and Injury, Burn Wound | Phase 4 | Completed | The Metis Foundation | 48 | 2021-02-08 | 2022-10-14 |
| Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain Lidocaine Hydrochloride, Liposomal bupivacaine, Bupivacaine Hydrochloride - Pain, Postoperative, Burns | Phase 4 | Completed | University of Kansas Medical Center | 74 | 2019-03-18 | 2026-03-31 |
| A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting Cefazolin, Clindamycin - Burn, Surgery | Phase 4 | Completed | Medstar Health Research Institute | 32 | 2018-05-29 | 2022-08-26 |
| Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns Rheosorbilact®, Ringer lactate - Burns, Intoxication | Phase 4 | Completed | Yuria-Pharm | 118 | 2017-02-02 | 2025-03-10 |
| Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects Albumins - Burns | Phase 4 | Completed | University Hospital, Linkoeping | 30 | 2016-10-01 | 2019-05-29 |
| TRANexamic Acid to Reduce Bleeding in BURN Surgery Tranexamic Acid, Placebo - Tranexamic Acid, Burns | Phase 4 | Completed | Centre Hospitalier Saint Joseph Saint Luc de Lyon | 121 | 2016-09-22 | 2024-04-04 |
| Oxycodone (10, 20 mg) in a Postoperative Dressing Oxycodone 10mg, Oxycodone 20mg - Burns | Phase 4 | Completed | Poznan University of Medical Sciences | 20 | 2016-01-01 | 2023-11-21 |
| Morphine (10, 20 mg) in a Postoperative Dressing Morphine Sulfate 10Mg/1mL Injection, Morphine Sulfate 20 MG/ML - Burns | Phase 4 | Completed | Poznan University of Medical Sciences | 20 | 2016-01-01 | 2026-11-12 |
| Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns Nanocrystalline silver, Silver Sulfadiazine - Second-degree Burn | Phase 4 | Completed | University of Sorocaba | 100 | 2013-11-01 | 2021-05-18 |
| Comparison of Wound Bed Establishment in Facial Burns Enzymatic agent, Bacitracin - Burns | Phase 4 | Completed | University of Louisville | 10 | 2012-02-01 | 2017-08-28 |
| Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns water-soluble therapy, silver sulfadiazine - Burn | Phase 4 | Completed | University of Virginia | 8 | 2011-04-01 | 2013-08-21 |
| An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns Wound coverage by acellular skin substitute, Autologous skin - Wound Healing, Scar Formation | Phase 4 | Completed | Medical University of Vienna | 18 | 2010-11-01 | 2011-10-19 |
| Pharmacokinetics Ertapenem Burns Ertapenem - Burn Patients | Phase 4 | Completed | Nantes University Hospital | 8 | 2010-01-01 | 2026-09-14 |
| Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream Titanium dioxide - Sunburn | Phase 4 | Completed | Loreal USA | 26 | 2009-12-01 | 2011-06-14 |
| Evaluation of Post Burn Rehabilitation Population for Itch Control Provase, Control moisturizer - Pruritus, Itching | Phase 4 | Completed | Swiss-American Products, Inc | 23 | 2006-09-01 | 2008-10-29 |
| Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing ceriumnitrate silversulfadiazine (flammacerium), silversulfadiazine (flammazine) - Burns | Phase 4 | Completed | Association of Dutch Burn Centres | 154 | 2006-03-01 | 2020-02-17 |
| Low-dose Hydrocortisone in Acutely Burned Patients hydrocortisone 200 mg/day - Burns | Phase 4 | Completed | Hospices Civils de Lyon | 40 | 2005-04-01 | 2015-02-12 |
Showing 20 of 22. Sign in to see all of them.
Wounds and Injuries (3) · Wound Infection (2) · Acute Pain (1) · Adrenal Insufficiency (1) · Agnosia (1) · Depression (1) · Drug-Related Side Effects and Adverse Reactions (1) · Facies (1) · Pain, Postoperative (1) · Postoperative Nausea and Vomiting (1) · Pruritus (1) · Respiratory Insufficiency (1) · Stress Disorders, Post-Traumatic (1) · Sunburn (1)
Wounds and Injuries (19) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Neurologic Manifestations (3) · Pathologic Processes (3) · Infections (2) · Pain (2) · Postoperative Complications (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adrenal Gland Diseases (1) · Avitaminosis (1) · Behavior (1) · Behavioral Symptoms (1)
Silver Sulfadiazine (3) · cerous nitrate, sulfadiazine silver drug combination (2) · ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1) · Acticoat (1) · Albumins (1) · Bacitracin (1) · Bupivacaine (1) · Cefazolin (1) · Clindamycin (1) · Ergocalciferols (1) · Ertapenem (1) · Gentamicins (1) · Hydrocortisone (1) · Injections (1) · Lidocaine (1)
Association of Dutch Burn Centres (2) · Poznan University of Medical Sciences (2) · Centre Hospitalier Saint Joseph Saint Luc de Lyon (1) · Dow University of Health Sciences (1) · Hospices Civils de Lyon (1) · Loreal USA (1) · Massachusetts General Hospital (1) · Medical University of Vienna (1) · Medstar Health Research Institute (1) · Nantes University Hospital (1) · Swiss-American Products, Inc (1) · The Metis Foundation (1) · University Hospital, Linkoeping (1) · University of Kansas Medical Center (1) · University of Louisville (1)
United States (8) · France (3) · Canada (2) · Netherlands (2) · Austria (1) · Brazil (1) · Kazakhstan (1) · Moldova (1) · Pakistan (1) · Sweden (1) · Ukraine (1) · Uzbekistan (1)
Marianne K Nieuwenhuis, PhD (2) · Bernadette Nedelec, BSc, OT, PhD (1) · Carlee R. Lehna, PhD, APRN-BC (1) · Frederick J Stoddard, M.D. (1) · Grzegorz Kowalski, Ph.D. (1) · Joachim Zdolsek, MD,PhD,Assoc prof (1) · Jonathan Black, MD (1) · Katarzyna Wieczorowska-Tobis, Prof.dr hab (1) · Lars P Kamolz, MD, PhD, MSc (1) · Leo LaSalle, M.D. (1) · Luciane C Lopes, PhD (1) · Maike Keck, MD (1) · Maria Pia Kabamalan (1) · Mathieu Fontaine, MD, PhD (1) · Nancy van Loey, PhD (1)
PMID 20828761, PMID 22040192, PMID 22842424, PMID 23578794, PMID 23641301, PMID 25619170, PMID 28623938, PMID 32366324, PMID 33350618, PMID 34216466, PMID 34688520, PMID 35141873, PMID 38767196, PMID 39375158